Skip to content

A randomized,controlled trial for the Bamboo medicinal moxibustion therapy of Ma's in the treatment of back pain caused by lumbar disc herniation

A randomized,controlled trial for the Bamboo medicinal moxibustion therapy of Ma's in the treatment of back pain caused by lumbar disc herniation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000004163
Enrollment
Unknown
Registered
2020-09-29
Start date
2020-10-10
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

back pain caused by lumbar disc herniation

Interventions

The experimental group: the Bamboo medicinal moxibustion therapy of Ma's

Sponsors

Guizhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) The above diagnostic criteria and pathological type were met, and the disease location was L3-S1; (2) Age 18-65, male or female; (3) Duration >=6 months; (4) Drug withdrawal is required for 4 weeks for drug users, and 2 weeks for non-drug users; (5) VAS score 3 to 6; (6) Sign the informed consent. Note: Only patients who meet the above 6 criteria can be included in this study.

Exclusion criteria

Exclusion criteria: (1) Acute back pain of lumbar disc herniation; (2) Lower back pain caused by other causes; (3) Patients with other diseases that need to be treated with anti-inflammatory and analgesic drugs; (4) Patients during pregnancy, lactation or preparation of pregnancy; (5) Those who have rashes, broken skin, ulcers or other infectious diseases in the waist; (6) Patients with heart, liver, kidney, blood system and other serious diseases; (7) Persons with mental disorders or communication disorders who cannot cooperate. Note: Patients who meet any of the above criteria should be excluded.

Design outcomes

Primary

MeasureTime frame
visual analogue scale;

Secondary

MeasureTime frame
modified Japanese Orthopaedic Association;beta-EP;SP;Oswestry disablity indes;

Countries

China

Contacts

Public ContactCuiJin
516260179@qq.c0m+86 13985026278

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026